Previous Chapter: Appendixes
Suggested Citation: "Appendix A: Agenda." National Academies of Sciences, Engineering, and Medicine. 2018. Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: Proceedings of a Symposium. Washington, DC: The National Academies Press. doi: 10.17226/24909.

Appendix A

Agenda

SYMPOSIUM DAY 1: MONDAY, JULY 17, 2017

International Atomic Energy Agency
Board Room A
M Building

9:00 Opening Session
Welcome

Meera Venkatesh, International Atomic Energy Agency (5 min)

Christophe Xerri, International Atomic Energy Agency (5 min)

Statement from the U.S. and Russian Academies

Stepan Kalmykov, co-chair, Russian Academy of Sciences (on behalf of the symposium organizing committees) (10 min)

9:20 Plenary Session

Moderator: Alexander Bychkov, Permanent Mission of the Russian Federation to the International Organizations in Vienna

Mo-99 production: Past, present, and future

Hedvig Hricak, co-chair, U.S. National Academies (on behalf of the symposium organizing committees) (10 min)

Russia’s role in global molybdenum-99 supply

Alexey Vakulenko, JSC V/O IZOTOP, Russian Federation (20 min)

Establishing and expanding nuclear medicine programs

Rodolfo Nuñez-Miller, International Atomic Energy Agency (10 min)

Wolfgang Weber, Memorial Sloan Kettering, United States (10 min)

Suggested Citation: "Appendix A: Agenda." National Academies of Sciences, Engineering, and Medicine. 2018. Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: Proceedings of a Symposium. Washington, DC: The National Academies Press. doi: 10.17226/24909.
Plenary session discussion (15 min)
10:30 BREAK
10:50 Molybdenum-99 Supply Reliability: Session 1

Moderator: Jack Coffey, Enigma Biomedical Group

Organisation for Economic Co-operation and Development-Nuclear Energy Agency’s principles to address molybdneum-99 supply reliability and the organization’s global market demand and production capacity projections

Kath Smith, High-Level Group on the Security of Supply of Medical Radioisotopes (15 min)

The European Commission’s efforts to evaluate the supply of medical radioisotopes

Margarida Goulart, European Commission (15 min)

Reactor schedule coordination for molybdenum-99 supply reliability

Bernard Ponsard, AIPES Reactors & Isotopes Working Group (15 min)

Investments in AREVA’s target production facility to improve long-term sustainable security of molybdenum-99 supply

Yann Guinard, AREVA, France (15 min)

Session 1 discussion (20 min)
12:10 Molybdenum-99 Supply: Session 2 (Part 1)

Moderator: Rania Kosti, U.S. National Academies

Existing global suppliers: Current production and future plans

Roy Brown, Curium (10 min)

Michael Druce, ANSTO, Australia (10 min)

Gavin Ball, NTP, South Africa (10 min)

Jean-Michel Vanderhofstadt, IRE, Belgium (10 min)

12:50 LUNCH
14:30 Molybdenum-99 Supply: Session 2 (Part 2)

Moderator: Rania Kosti, U.S. National Academies

New projects for regional or global molybdenum-99 supply

James Harvey, NorthStar, United States (10 min)

Katrina Pitas, SHINE, United States (10 min)

Carolyn Haass, Northwest Medical Isotopes, LLC, United States (10 min)

Carmen Bigles, Coquí Radio Pharmaceuticals, United States (10 min)

Matthew Lish, Flibe Energy, United States (10 min)

Hermen van der Lugt, PALLAS Reactor, Netherlands (10 min)

Oleg Kononov, Karpov Scientific Research Institute of Physics and Chemistry, Russian Federation (10 min)

Ken Buckley, TRIUMF, Canada (10 min)

Kennedy Mang’era, Canadian Isotope Innovations Corp. (10 min)

Jin Du, China Isotope & Radiation Corporation (10 min)

Suggested Citation: "Appendix A: Agenda." National Academies of Sciences, Engineering, and Medicine. 2018. Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: Proceedings of a Symposium. Washington, DC: The National Academies Press. doi: 10.17226/24909.

Anupam Mathur, Department of Atomic Energy, India (10 min)

Ul-Jae Park, Korea Atomic Energy Research Institute (10 min)

Pablo Cristini, National Atomic Energy Commission, Argentina (10 min)

Mostafa Abd Elaal, Egyptian Atomic Energy Authority (10 min)

Session 2 discussion (30 min)
17:30 Late afternoon break and closing remarks

(Participants move to MO2 Foyer)

19:30 Adjourn symposium day 1

SYMPOSIUM DAY 2: TUESDAY, JULY 18, 2017

Board Room A
M Building

9:00 Welcome

Stepan Kalmykov, co-chair, Russian Academy of Sciences committee (on behalf of the two Academies) (5 min)

9:05 Technical Considerations: Session 3

Moderator: Boris Zhuikov, Russian Academy of Sciences

Conversion to low enriched uranium-based molybdenum-99 production

Jean-Michel Vanderhofstadt, IRE, Belgium (10 min)

Roy Brown, Curium (10 min)

Gavin Ball, NTP, South Africa (10 min)

Vladimir Risovaniy, Rosatom, Russian Federation (10 min)

Production expansion

Michael Druce, ANSTO, Australia (10 min)

Prospects for the use of activation of molybdenum for the production of technetium-99m generators

Victor Skuridin, Tomsk Polytechnic University, Russian Federation (15 min)

High-density low-enriched uranium targets production

Bertrand Stepnik, AREVA, France (15 min)

Kinam Kim, Korea Atomic Energy Research Institute (15 min)

Session 3 discussion (20 min)
11:40 BREAK
12:00 Regulatory Considerations: Session 4

Moderator: Joao Alberto Osso Junior, International Atomic Energy Agency

European Medicines Agency’s regulatory considerations

Brendan Cuddy, European Medicines Agency (20 min, pre-recorded)

Suggested Citation: "Appendix A: Agenda." National Academies of Sciences, Engineering, and Medicine. 2018. Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: Proceedings of a Symposium. Washington, DC: The National Academies Press. doi: 10.17226/24909.

Perspectives from Tc-99m generator manufacturers

Ira Goldman, Lantheus Medical Imaging, United States (10 min)

Roy Brown, Curium, Netherlands (10 min)

Perspectives from a nuclear pharmacy

David Pellicciarini, Cardinal Health, United States (15 min)

Session 4 discussion (15 min)
13:15 LUNCH
14:30 Economic Considerations: Session 5

Moderator: Charles Ferguson, Federation of American Scientists

Molybdenum-99 supply economics

Jan Willem Velthuijsen, PwC Europe (20 min)

Low-enriched uranium-based molybdenum-99 production

Gavin Ball, NTP (5 min)

Michael Druce, ANSTO (5 min)

Session 5 discussion (25 min)
15:30 BREAK
15:50 Chemical Processing and Waste Management: Session 6

Moderator: Sergey Yudintsev, Russian Academy of Sciences

Chemical processing and waste management following neutron activation

Evgeniy Nesterov, Tomsk Polytechnic University, Russian Federation (10 min)

Development of a novel dry chemical uranium molybdenum separation: Research for a future efficient Mo-99 extraction process

Riane Stene, FRM-II, Germany (10 min)

Waste management in HEU versus LEU-based molybdenum-99 production

Jean-Michel Vanderhofstadt, IRE, Belgium (15 min)

Synroc Technology for the Management of molybdenum-99 Waste

Bruce Begg, ANSTO, Australia (10 min)

Recycling processed LEU for reuse as target material

Carolyn Haass, Northwest Medical Isotopes, LLC, United States (10 min)

Session 6 discussion (30 min)
17:20 Closing remarks

Stepan Kalmykov, co-chair, Russian Academy of Sciences

17:30 Adjourn symposium
Suggested Citation: "Appendix A: Agenda." National Academies of Sciences, Engineering, and Medicine. 2018. Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: Proceedings of a Symposium. Washington, DC: The National Academies Press. doi: 10.17226/24909.
Page 51
Suggested Citation: "Appendix A: Agenda." National Academies of Sciences, Engineering, and Medicine. 2018. Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: Proceedings of a Symposium. Washington, DC: The National Academies Press. doi: 10.17226/24909.
Page 52
Suggested Citation: "Appendix A: Agenda." National Academies of Sciences, Engineering, and Medicine. 2018. Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: Proceedings of a Symposium. Washington, DC: The National Academies Press. doi: 10.17226/24909.
Page 53
Suggested Citation: "Appendix A: Agenda." National Academies of Sciences, Engineering, and Medicine. 2018. Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets: Proceedings of a Symposium. Washington, DC: The National Academies Press. doi: 10.17226/24909.
Page 54
Next Chapter: Appendix B: Biographical Sketches of Committee Members, Presenters, and Moderators
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.